LENZ Therapeutics, Inc. (LENZ) Preferred Stock Liabilities (2022 - 2023)
LENZ Therapeutics (LENZ) has disclosed Preferred Stock Liabilities for 1 consecutive years, with $5.9 million as the latest value for Q3 2023.
LENZ Therapeutics (LENZ) has disclosed Preferred Stock Liabilities for 1 consecutive years, with $5.9 million as the latest value for Q3 2023.